Does RISANKIZUMAB Cause Therapeutic product effect incomplete? 45 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Therapeutic product effect incomplete have been filed in association with RISANKIZUMAB (Skyrizi). This represents 1.7% of all adverse event reports for RISANKIZUMAB.
45
Reports of Therapeutic product effect incomplete with RISANKIZUMAB
1.7%
of all RISANKIZUMAB reports
0
Deaths
15
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From RISANKIZUMAB?
Of the 45 reports, 15 (33.3%) required hospitalization.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB. However, 45 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB Cause?
Product storage error (396)
Drug ineffective (206)
Psoriasis (138)
Crohn's disease (103)
Arthralgia (100)
Off label use (100)
Product temperature excursion issue (88)
Diarrhoea (72)
Fatigue (70)
Rash (64)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which RISANKIZUMAB Alternatives Have Lower Therapeutic product effect incomplete Risk?
RISANKIZUMAB vs RISANKIZUMAB-RZAA
RISANKIZUMAB vs RISDIPLAM
RISANKIZUMAB vs RISEDRONATE
RISANKIZUMAB vs RISEDRONIC ACID
RISANKIZUMAB vs RISPERDAL